Report Cover

United States Atrial Appendage Occluder Market Report & Forecast 2021-2027


United States Atrial Appendage Occluder Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
United States Atrial Appendage Occluder Market Segment Percentages, By Type, 2020 (%)
    Valvular Atrial Fibrillation
    Non-valvular Atrial Fibrillation

United States Atrial Appendage Occluder Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)
United States Atrial Appendage Occluder Market Segment Percentages, By Application, 2020 (%)
    Clinics
    Hospitals

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Atrial Appendage Occluder revenues in United States market, 2016-2021 (Estimated), ($ millions)
Key companies Atrial Appendage Occluder revenues share in United States market, 2020 (%)
Key companies Atrial Appendage Occluder sales in United States market, 2016-2021 (Estimated), (K Units)
Key companies Atrial Appendage Occluder sales share in United States market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Boston Scientific
    SentreHEART Inc.
    Occlutech
    AtriCure
    Appriva Medical Inc.
    Abbott
    PFM Medical Ag.
    W. L. Gore & Associates
    Cardia, Inc.
    Coherex Medical
1 Introduction to Research & Analysis Reports
    1.1 Atrial Appendage Occluder Market Definition
    1.2 Market Segments
        1.2.1 Segment by Type
        1.2.2 Segment by Application
    1.3 United States Atrial Appendage Occluder Market Overview
    1.4 Methodology & Sources of Information
        1.4.1 Research Methodology
        1.4.2 Research Process
        1.4.3 Base Year

2 United States Atrial Appendage Occluder Overall Market Size
    2.1 United States Atrial Appendage Occluder Market Size: 2021 VS 2027
    2.2 United States Atrial Appendage Occluder Revenue, Prospects & Forecasts: 2016-2027
    2.3 United States Atrial Appendage Occluder Sales: 2016-2027

3 Company Landscape
    3.1 Top Atrial Appendage Occluder Players in United States Market
    3.2 Top United States Atrial Appendage Occluder Companies Ranked by Revenue
    3.3 United States Atrial Appendage Occluder Revenue by Companies
    3.4 United States Atrial Appendage Occluder Sales by Companies
    3.5 United States Atrial Appendage Occluder Price by Manufacturer (2016-2021)
    3.6 Top 3 and Top 5 Atrial Appendage Occluder Companies in United States Market, by Revenue in 2020
    3.7 Manufacturers Atrial Appendage Occluder Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Atrial Appendage Occluder Players in United States Market
        3.8.1 List of Tier 1 Atrial Appendage Occluder Companies in United States
        3.8.2 List of Tier 2 and Tier 3 Atrial Appendage Occluder Companies in United States

4 Sights by Type
    4.1 Overview
        4.1.1 By Type - United States Atrial Appendage Occluder Market Size Markets, 2021 & 2027
        4.1.2 Valvular Atrial Fibrillation
        4.1.3 Non-valvular Atrial Fibrillation
    4.2 By Type - United States Atrial Appendage Occluder Revenue & Forecasts
        4.2.1 By Type - United States Atrial Appendage Occluder Revenue, 2016-2021
        4.2.2 By Type - United States Atrial Appendage Occluder Revenue, 2022-2027
        4.2.3 By Type - United States Atrial Appendage Occluder Revenue Market Share, 2016-2027
    4.3 By Type - United States Atrial Appendage Occluder Sales & Forecasts
        4.3.1 By Type - United States Atrial Appendage Occluder Sales, 2016-2021
        4.3.2 By Type - United States Atrial Appendage Occluder Sales, 2022-2027
        4.3.3 By Type - United States Atrial Appendage Occluder Sales Market Share, 2016-2027
    4.4 By Type - United States Atrial Appendage Occluder Price (Manufacturers Selling Prices), 2016-2027

5 Sights by Application
    5.1 Overview
        5.1.1 By Application - United States Atrial Appendage Occluder Market Size, 2021 & 2027
        5.1.2 Clinics
        5.1.3 Hospitals
    5.2 By Application - United States Atrial Appendage Occluder Revenue & Forecasts
        5.2.1 By Application - United States Atrial Appendage Occluder Revenue, 2016-2021
        5.2.2 By Application - United States Atrial Appendage Occluder Revenue, 2022-2027
        5.2.3 By Application - United States Atrial Appendage Occluder Revenue Market Share, 2016-2027
    5.3 By Application - United States Atrial Appendage Occluder Sales & Forecasts
        5.3.1 By Application - United States Atrial Appendage Occluder Sales, 2016-2021
        5.3.2 By Application - United States Atrial Appendage Occluder Sales, 2022-2027
        5.3.3 By Application - United States Atrial Appendage Occluder Sales Market Share, 2016-2027
    5.4 By Application - United States Atrial Appendage Occluder Price (Manufacturers Selling Prices), 2016-2027

6 Manufacturers & Brands Profiles
    6.1 Boston Scientific
        6.1.1 Boston Scientific Corporation Information
        6.1.2 Boston Scientific Overview
        6.1.3 Boston Scientific Atrial Appendage Occluder Sales and Revenue in United States Market (2016-2021)
        6.1.4 Boston Scientific Atrial Appendage Occluder Product Description
        6.1.5 Boston Scientific Recent Developments
    6.2 SentreHEART Inc.
        6.2.1 SentreHEART Inc. Corporation Information
        6.2.2 SentreHEART Inc. Overview
        6.2.3 SentreHEART Inc. Atrial Appendage Occluder Sales and Revenue in United States Market (2016-2021)
        6.2.4 SentreHEART Inc. Atrial Appendage Occluder Product Description
        6.2.5 SentreHEART Inc. Recent Developments
    6.3 Occlutech
        6.3.1 Occlutech Corporation Information
        6.3.2 Occlutech Overview
        6.3.3 Occlutech Atrial Appendage Occluder Sales and Revenue in United States Market (2016-2021)
        6.3.4 Occlutech Atrial Appendage Occluder Product Description
        6.3.5 Occlutech Recent Developments
    6.4 AtriCure
        6.4.1 AtriCure Corporation Information
        6.4.2 AtriCure Overview
        6.4.3 AtriCure Atrial Appendage Occluder Sales and Revenue in United States Market (2016-2021)
        6.4.4 AtriCure Atrial Appendage Occluder Product Description
        6.4.5 AtriCure Recent Developments
    6.5 Appriva Medical Inc.
        6.5.1 Appriva Medical Inc. Corporation Information
        6.5.2 Appriva Medical Inc. Overview
        6.5.3 Appriva Medical Inc. Atrial Appendage Occluder Sales and Revenue in United States Market (2016-2021)
        6.5.4 Appriva Medical Inc. Atrial Appendage Occluder Product Description
        6.5.5 Appriva Medical Inc. Recent Developments
    6.6 Abbott
        6.6.1 Abbott Corporation Information
        6.6.2 Abbott Overview
        6.6.3 Abbott Atrial Appendage Occluder Sales and Revenue in United States Market (2016-2021)
        6.6.4 Abbott Atrial Appendage Occluder Product Description
        6.6.5 Abbott Recent Developments
    6.7 PFM Medical Ag.
        6.7.1 PFM Medical Ag. Corporation Information
        6.7.2 PFM Medical Ag. Overview
        6.7.3 PFM Medical Ag. Atrial Appendage Occluder Sales and Revenue in United States Market (2016-2021)
        6.7.4 PFM Medical Ag. Atrial Appendage Occluder Product Description
        6.7.5 PFM Medical Ag. Recent Developments
    6.8 W. L. Gore & Associates
        6.8.1 W. L. Gore & Associates Corporation Information
        6.8.2 W. L. Gore & Associates Overview
        6.8.3 W. L. Gore & Associates Atrial Appendage Occluder Sales and Revenue in United States Market (2016-2021)
        6.8.4 W. L. Gore & Associates Atrial Appendage Occluder Product Description
        6.8.5 W. L. Gore & Associates Recent Developments
    6.9 Cardia, Inc.
        6.9.1 Cardia, Inc. Corporation Information
        6.9.2 Cardia, Inc. Overview
        6.9.3 Cardia, Inc. Atrial Appendage Occluder Sales and Revenue in United States Market (2016-2021)
        6.9.4 Cardia, Inc. Atrial Appendage Occluder Product Description
        6.9.5 Cardia, Inc. Recent Developments
    6.10 Coherex Medical
        6.10.1 Coherex Medical Corporation Information
        6.10.2 Coherex Medical Overview
        6.10.3 Coherex Medical Atrial Appendage Occluder Sales and Revenue in United States Market (2016-2021)
        6.10.4 Coherex Medical Atrial Appendage Occluder Product Description
        6.10.5 Coherex Medical Recent Developments

7 United States Atrial Appendage Occluder Production Capacity, Analysis
    7.1 United States Atrial Appendage Occluder Production Capacity, 2016-2027
    7.2 Atrial Appendage Occluder Production Capacity of Key Manufacturers in United States Market

8 Key Market Trends, Opportunity, Drivers and Restraints
    8.1 Market Opportunities & Trends
    8.2 Market Drivers
    8.3 Market Restraints

9 Atrial Appendage Occluder Supply Chain Analysis
    9.1 Atrial Appendage Occluder Industry Value Chain
    9.2 Atrial Appendage Occluder Upstream Market
    9.3 Atrial Appendage Occluder Downstream and Clients
    9.4 Marketing Channels Analysis
        9.4.1 Marketing Channels
        9.4.2 Atrial Appendage Occluder Distributors and Sales Agents in United States Market

10 Conclusion
11 Appendix
    11.1 Note
    11.2 Examples of Clients
    11.3 Author Details
    11.4 Disclaimer

List of Tables Table 1. Key Players of Atrial Appendage Occluder in United States Market Table 2. Top Atrial Appendage Occluder Players in United States Market, Ranking by Revenue (2019) Table 3. United States Atrial Appendage Occluder Revenue by Companies, (US$, Mn), 2016-2021 Table 4. United States Atrial Appendage Occluder Revenue Share by Companies, 2016-2021 Table 5. United States Atrial Appendage Occluder Sales by Companies, (K Units), 2016-2021 Table 6. United States Atrial Appendage Occluder Sales Share by Companies, 2016-2021 Table 7. Key Manufacturers Atrial Appendage Occluder Price (2016-2021) & (US$/Unit) Table 8. Manufacturers Atrial Appendage Occluder Product Type Table 9. List of Tier 1 Atrial Appendage Occluder Companies, Revenue (US$, Mn) in 2020 and Market Share Table 10. List of Tier 2 and Tier 3 Atrial Appendage Occluder Companies, Revenue (US$, Mn) in 2020 and Market Share Table 11. Major Manufacturers of Valvular Atrial Fibrillation Table 12. Major Manufacturers of Non-valvular Atrial Fibrillation Table 13. By Type - United States Atrial Appendage Occluder Revenue, (US$, Mn), 2021 & 2027 Table 14. By Type - United States Atrial Appendage Occluder Revenue (US$, Mn), 2016-2021 Table 15. By Type - United States Atrial Appendage Occluder Revenue (US$, Mn), 2022-2027 Table 16. By Type - United States Atrial Appendage Occluder Sales (K Units), 2016-2021 Table 17. By Type - United States Atrial Appendage Occluder Sales (K Units), 2022-2027 Table 18. By Application - United States Atrial Appendage Occluder Revenue, (US$, Mn), 2021 VS 2027 Table 19. By Application - United States Atrial Appendage Occluder Revenue (US$, Mn), 2016-2021 Table 20. By Application - United States Atrial Appendage Occluder Revenue (US$, Mn), 2022-2027 Table 21. By Application - United States Atrial Appendage Occluder Sales (K Units), 2016-2021 Table 22. By Application - United States Atrial Appendage Occluder Sales (K Units), 2022-2027 Table 23. Boston Scientific Corporation Information Table 24. Boston Scientific Description and Major Businesses Table 25. Boston Scientific Atrial Appendage Occluder Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) Table 26. Boston Scientific Atrial Appendage Occluder Product Table 27. Boston Scientific Recent Developments Table 28. SentreHEART Inc. Corporation Information Table 29. SentreHEART Inc. Description and Major Businesses Table 30. SentreHEART Inc. Atrial Appendage Occluder Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) Table 31. SentreHEART Inc. Atrial Appendage Occluder Product Table 32. SentreHEART Inc. Recent Developments Table 33. Occlutech Corporation Information Table 34. Occlutech Description and Major Businesses Table 35. Occlutech Atrial Appendage Occluder Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) Table 36. Occlutech Atrial Appendage Occluder Product Table 37. Occlutech Recent Developments Table 38. AtriCure Corporation Information Table 39. AtriCure Description and Major Businesses Table 40. AtriCure Atrial Appendage Occluder Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) Table 41. AtriCure Atrial Appendage Occluder Product Table 42. AtriCure Recent Developments Table 43. Appriva Medical Inc. Corporation Information Table 44. Appriva Medical Inc. Description and Major Businesses Table 45. Appriva Medical Inc. Atrial Appendage Occluder Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) Table 46. Appriva Medical Inc. Atrial Appendage Occluder Product Table 47. Appriva Medical Inc. Recent Developments Table 48. Abbott Corporation Information Table 49. Abbott Description and Major Businesses Table 50. Abbott Atrial Appendage Occluder Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) Table 51. Abbott Atrial Appendage Occluder Product Table 52. Abbott Recent Developments Table 53. PFM Medical Ag. Corporation Information Table 54. PFM Medical Ag. Description and Major Businesses Table 55. PFM Medical Ag. Atrial Appendage Occluder Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) Table 56. PFM Medical Ag. Atrial Appendage Occluder Product Table 57. PFM Medical Ag. Recent Developments Table 58. W. L. Gore & Associates Corporation Information Table 59. W. L. Gore & Associates Description and Major Businesses Table 60. W. L. Gore & Associates Atrial Appendage Occluder Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) Table 61. W. L. Gore & Associates Atrial Appendage Occluder Product Table 62. W. L. Gore & Associates Recent Developments Table 63. Cardia, Inc. Corporation Information Table 64. Cardia, Inc. Description and Major Businesses Table 65. Cardia, Inc. Atrial Appendage Occluder Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) Table 66. Cardia, Inc. Atrial Appendage Occluder Product Table 67. Cardia, Inc. Recent Developments Table 68. Coherex Medical Corporation Information Table 69. Coherex Medical Description and Major Businesses Table 70. Coherex Medical Atrial Appendage Occluder Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) Table 71. Coherex Medical Atrial Appendage Occluder Product Table 72. Coherex Medical Recent Developments Table 73. Atrial Appendage Occluder Production Capacity (K Units) of Key Manufacturers in United States Market, 2019-2021 (K Units) Table 74. United States Atrial Appendage Occluder Capacity Market Share of Key Manufacturers, 2019-2021 Table 75. Atrial Appendage Occluder Market Opportunities & Trends in United States Market Table 76. Atrial Appendage Occluder Market Drivers in United States Market Table 77. Atrial Appendage Occluder Market Restraints in United States Market Table 78. Atrial Appendage Occluder Raw Materials Table 79. Atrial Appendage Occluder Raw Materials Suppliers in United States Market Table 80. Typical Atrial Appendage Occluder Downstream Table 81. Atrial Appendage Occluder Downstream Clients in United States Market Table 82. Atrial Appendage Occluder Distributors and Sales Agents in United States Market List of Figures Figure 1. Atrial Appendage Occluder Product Picture Figure 2. Atrial Appendage Occluder Segment by Type Figure 3. Atrial Appendage Occluder Segment by Application Figure 4. United States Atrial Appendage Occluder Market Overview: 2020 Figure 5. United States Atrial Appendage Occluder Market Size: 2021 VS 2027 (US$, Mn) Figure 6. United States Atrial Appendage Occluder Revenue, 2016-2027 (US$, Mn) Figure 7. Atrial Appendage Occluder Sales in United States Market: 2016-2027 (K Units) Figure 8. The Top 3 and 5 Players Market Share by Atrial Appendage Occluder Revenue in 2020 Figure 9. Valvular Atrial Fibrillation Product Picture Figure 10. Non-valvular Atrial Fibrillation Product Picture Figure 11. By Type - United States Atrial Appendage Occluder Sales Market Share, 2016-2027 Figure 12. By Type - United States Atrial Appendage Occluder Revenue Market Share, 2016-2027 Figure 13. By Type - United States Atrial Appendage Occluder Price (US$/Unit), 2016-2027 Figure 14. Clinics Figure 15. Hospitals Figure 16. By Application - United States Atrial Appendage Occluder Sales Market Share, 2016-2027 Figure 17. By Application - United States Atrial Appendage Occluder Revenue Market Share, 2016-2027 Figure 18. By Application - United States Atrial Appendage Occluder Price (US$/Unit), 2016-2027 Figure 19. Boston Scientific Atrial Appendage Occluder Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 20. SentreHEART Inc. Atrial Appendage Occluder Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 21. Occlutech Atrial Appendage Occluder Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 22. AtriCure Atrial Appendage Occluder Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 23. Appriva Medical Inc. Atrial Appendage Occluder Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 24. Abbott Atrial Appendage Occluder Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 25. PFM Medical Ag. Atrial Appendage Occluder Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 26. W. L. Gore & Associates Atrial Appendage Occluder Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 27. Cardia, Inc. Atrial Appendage Occluder Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 28. Coherex Medical Atrial Appendage Occluder Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 29. United States Atrial Appendage Occluder Production Capacity (K Units), 2016-2027 Figure 30. Atrial Appendage Occluder Industry Value Chain Figure 31. Marketing Channels

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us